Research Frontiers Incorporated
$ 0.71
-3.92%
12 Jun - close price
- Market Cap 24,756,100 USD
- Current Price $ 0.71
- High / Low $ 0.75 / 0.71
- Stock P/E N/A
- Book Value 0.05
- EPS -0.07
- Next Earning Report 2026-08-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.44 %
- ROE -1.14 %
- 52 Week High 2.70
- 52 Week Low 0.71
About
Research Frontiers Incorporated develops and markets technology and devices to control the flow of light globally. The company is headquartered in Woodbury, New York.
Analyst Target Price
$3.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-03-05 | 2025-11-06 | 2025-08-07 | 2025-05-08 | 2025-03-06 | 2024-11-07 | 2024-08-01 | 2024-05-09 | 2024-03-07 | 2023-11-02 | 2023-08-03 |
| Reported EPS | -0.0154 | -0.0228 | -0.0089 | -0.03 | -0.0053 | -0.0181 | -0.005 | -0.0028 | -0.0132 | -0.0143 | -0.0141 | -0.0147 |
| Estimated EPS | None | None | 0 | 0 | None | None | None | None | None | None | None | None |
| Surprise | 0 | 0 | -0.0089 | -0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-06 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: REFR
2026-06-06 12:39:06
Research Frontiers Inc. (NASDAQ: REFR) received two deficiency notices from Nasdaq on June 2, 2026, for failing to meet the minimum bid price of $1.00 and the minimum market value of listed securities of $35 million for 30 consecutive business days. The company has 180 calendar days, until November 30, 2026, to regain compliance for both requirements, with potential actions including a reverse stock split. Failure to comply could lead to delisting, significantly impacting share liquidity and valuation.
2026-06-06 07:10:11
Research Frontiers Incorporated (NASDAQ: REFR) has received deficiency notices from Nasdaq for failing to meet the minimum $1.00 bid price and $35 million Market Value of Listed Securities requirements. The company has 180 calendar days, until November 30, 2026, to regain compliance by maintaining these thresholds for at least ten consecutive business days. Research Frontiers intends to improve its market valuation rather than conducting a reverse stock split.
2026-06-05 21:10:12
Research Frontiers (REFR) announced it received two Nasdaq deficiency notices on June 2, 2026, for failing to meet the minimum bid price and market value of listed securities requirements for 30 consecutive business days. The company, which trades on The Nasdaq Capital Market, has until November 30, 2026, to regain compliance and does not currently plan a reverse stock split. This information was based on an original SEC Filing on June 5, 2026.
2026-05-31 18:39:36
The article analyzes the valuation of Research Frontiers Inc (REFR), stating it is currently undervalued with a fair price range of $1.35 to $2.36, compared to its current price of $0.77. Despite this, REFR's P/S ratio of 10.76 is significantly above the industry average, which the article suggests is unsustainable given its negative revenue growth. Key valuation metrics like P/B ratio, FCF yield, and Forward P/E are also detailed, showing current figures and comparisons to historical averages and industry benchmarks.
2026-05-30 03:09:51
This article provides recent news headlines related to Research Frontiers Incorporated (REFR). It highlights REFR's stock performance, showing a slight increase, and includes past news from May 2021 about unrelated companies like Annovis Bio, Inc. and ViacomCBS. The content mostly serves as an aggregate of financial news, also listing tools and market indicators.
2026-05-21 08:39:16
Research Frontiers' Q1 earnings call revealed a mix of financial strengthening and legal uncertainties. The company significantly improved its cash position and saw royalty recovery, but faces pressure from accounting timing and ongoing French rehabilitation proceedings. Investors are advised to watch the upcoming French court decision and licensee stability alongside the company's long-term growth prospects.
